134 related articles for article (PubMed ID: 34388303)
1. Association between Hydroxychloroquine and bacterial pneumonia in rheumatic patients: A population-based propensity score matching cohort study.
Lin SY; Lin CL; Chang SS; Hsu WH; Lin CC; Kao CH
Int J Clin Pract; 2021 Nov; 75(11):e14737. PubMed ID: 34388303
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.
Lo CH; Wei JC; Wang YH; Tsai CF; Chan KC; Li LC; Lo TH; Su CH
Front Immunol; 2021; 12():631869. PubMed ID: 33868251
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: A nationwide population-based cohort study.
Hung YM; Wang YH; Lin L; Wang PYP; Chiou JY; Wei JC
Int J Clin Pract; 2018 May; 72(5):e13095. PubMed ID: 29691971
[TBL] [Abstract][Full Text] [Related]
4. Risk of uveitis in autoimmune diseases patients treated with hydroxychloroquine: A population-based retrospective cohort study.
Bai YC; Perng WT; Huang JY; Liao PL; Wei JC
Int J Rheum Dis; 2024 Mar; 27(3):e15099. PubMed ID: 38450965
[TBL] [Abstract][Full Text] [Related]
5. Effect of long-term hydroxychloroquine on vascular events in patients with systemic lupus erythematosus: a database prospective cohort study.
Hsu CY; Lin YS; Su YJ; Lin HF; Lin MS; Syu YJ; Cheng TT; Yu SF; Chen JF; Chen TH
Rheumatology (Oxford); 2017 Dec; 56(12):2212-2221. PubMed ID: 29029334
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine use is associated with reduced mortality risk in older adults with rheumatoid arthritis.
Iyer P; Gao Y; Jalal D; Girotra S; Singh N; Vaughan-Sarrazin M
Clin Rheumatol; 2024 Jan; 43(1):87-94. PubMed ID: 37498463
[TBL] [Abstract][Full Text] [Related]
7. Effect of hydroxychloroquine on preeclampsia in lupus pregnancies: a propensity score-matched analysis and meta-analysis.
Liu Y; Zhang Y; Wei Y; Yang H
Arch Gynecol Obstet; 2021 Feb; 303(2):435-441. PubMed ID: 32880707
[TBL] [Abstract][Full Text] [Related]
8. Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study.
Jung SY; Kim MS; Kim MC; Choi SH; Chung JW; Choi ST
Clin Microbiol Infect; 2021 Apr; 27(4):611-617. PubMed ID: 33316402
[TBL] [Abstract][Full Text] [Related]
9. Current screening practice in patients under long-term hydroxychloroquine medication in Taiwan: A nationwide population-based cohort study.
Yen CY; Lee PH; Yen JC; Chen CC; Hu HY; Tseng PC
Medicine (Baltimore); 2019 Apr; 98(14):e15122. PubMed ID: 30946384
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
Chen YM; Lin CH; Lan TH; Chen HH; Chang SN; Chen YH; Wang JS; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine was associated with reduced risk of new-onset diabetes mellitus in patients with Sjögren syndrome.
Chen TH; Lai TY; Wang YH; Chiou JY; Hung YM; Wei JC
QJM; 2019 Oct; 112(10):757-762. PubMed ID: 31218368
[TBL] [Abstract][Full Text] [Related]
12. Adherence to hydroxychloroquine improves long-term survival of patients with systemic lupus erythematosus.
Hsu CY; Lin YS; Cheng TT; Syu YJ; Lin MS; Lin HF; Su YJ; Chen YC; Chen JF; Chen TH
Rheumatology (Oxford); 2018 Oct; 57(10):1743-1751. PubMed ID: 29931367
[TBL] [Abstract][Full Text] [Related]
13. Baseline use of hydroxychloroquine or immunosuppressive drugs and the risk of coronavirus disease 2019.
Kim JW; Kwak SG; Lee H; Kim SK; Choe JY; Park SH
Korean J Intern Med; 2022 May; 37(3):673-680. PubMed ID: 33706472
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study.
Mao IC; Lin CY; Wu CL; Kor CT; Chang CC
Ther Clin Risk Manag; 2018; 14():1435-1443. PubMed ID: 30154660
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine might reduce risk of incident endometriosis in patients with systemic lupus erythematosus: A retrospective population-based cohort study.
Chen FY; Chen SW; Chen X; Huang JY; Ye Z; Wei JC
Lupus; 2021 Sep; 30(10):1609-1616. PubMed ID: 34259057
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study.
Fernandez-Ruiz R; Bornkamp N; Kim MY; Askanase A; Zezon A; Tseng CE; Belmont HM; Saxena A; Salmon JE; Lockshin M; Buyon JP; Izmirly PM
Arthritis Res Ther; 2020 Aug; 22(1):191. PubMed ID: 32807233
[TBL] [Abstract][Full Text] [Related]
17. Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases.
Rekedal LR; Massarotti E; Garg R; Bhatia R; Gleeson T; Lu B; Solomon DH
Arthritis Rheum; 2010 Dec; 62(12):3569-73. PubMed ID: 20722019
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine had neutral effect on long-term risk of malignancy in rheumatoid arthritis patients: A population-based retrospective cohort study.
Hou XJ; Chang R; Wang YH; Kang TL; Wei JC
Int J Rheum Dis; 2024 Mar; 27(3):e15102. PubMed ID: 38450839
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy of Long-Term Hydroxychloroquine Use in the Prevention of COVID-19: A Retrospective Cohort Study.
Finkelstein J; Huo X
Stud Health Technol Inform; 2023 Jun; 305():303-306. PubMed ID: 37387023
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis.
Liu D; Li X; Zhang Y; Kwong JS; Li L; Zhang Y; Xu C; Li Q; Sun X; Tian H; Li S
Drug Des Devel Ther; 2018; 12():1685-1695. PubMed ID: 29928112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
